Pulmonary arterial hypertension in systemic sclerosis: Definition of a screening algorithm for early detection (the ItinérAIR- Sclérodermie Study);L'hypertension artérielle pulmonaire associée à la sclérodermie systémique: Proposition d'un algorithme échocardiographique de dépistage pour un diagnostic précoce (ItinérAIR-Sclérodermie)

Revue de Medecine Interne

Volumn 25, Issue 5, 2004, Pages 340-347

  Hachulla, E ^a   Gressin, V ^b   Guillevin, L ^c   De Groote, P ^a   Cabane, J ^d   Carpentier, P ^e   Frances C ^f   Kahan, A ^c   Humbert, M ^g  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Actelion Pharmaceuticals France   (France)

^c Hôpital Cochin ^*  (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Algorithme de d pistage; Cath t risme cardiaque droit; DLCO; cho doppler cardiaque; Hypertension art rielle pulmonaire; Pulmonary arterial hypertension; Scleroderma; Scl rodermie syst mique

Indexed keywords

ALGORITHM; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPPLER ECHOCARDIOGRAPHY; EARLY DIAGNOSIS; FRANCE; HIGH RISK PATIENT; HUMAN; MEDICAL LITERATURE; MEDICAL PRACTICE; PREDICTION; PREVALENCE; PULMONARY HYPERTENSION; RISK ASSESSMENT; SCLERODERMA; SCREENING; SYSTEMIC SCLEROSIS; TRICUSPID VALVE REGURGITATION;

EID: 2142805864     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.01.019     Document Type: Article

References (23)

1. Le Guern V., Mahr A., Mouthon L., Jeanneret D., Carzon M., Guillevin L. Prevalence of systemic sclerosis (SSc) in a French urban multiethnic county. Arthritis Rheum. 48:(Suppl):2003;S391
2. Carpentier P.H., Feuillade M.L., Santacreu J.M., Arnaud J., Imbert B., Franco A. Variations géographiques de la prévalence et de l'incidence de la sclérodermie systématique. Rev Méd Interne. 20:(suppl 6):1999;560s
3. Primary pulmonary hypertension. Executive summary from the World Symposium. Rich S. Primary Pulmonary hypertension. 1998;. Evian, France
4. Recommendations on the management of pulmonary hypertension in clinical practice. Heart. 86:(1 S):2001;i1-i13. British Cardiac Guidelines and Medical Practice Committee and approved by British Thoracic Society and British Society of Rheumatology
5. Ungerer R.G., Tashkin D.P., Furst D., Clements P.J., Gong H., Bein M., et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med. 75:1983;65-74
6. Murata I., Kihara H., Shinohara S., Ito K. Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes. Jpn Circ J. 56:1992;983-991
7. Battle R.W., Davitt M.A., Cooper S.M., Buckley L.M., Leib E.S., Beglin P.A., et al. Prevalence of pulmonary arterial hypertension in limited and diffuse scleroderma. Chest. 110:1996;1515-1519
8. Koh E.T., Lee P., Gladman D.D., Abu-Shakra M. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br Rheumatol. 35:1996;989-993
9. MacGregor A.J., Canavan R., Knight C., Denton C.P., Davar J., Coghlan J., et al. Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology. 40:2001;453-459
10. Launay D., Hachulla E., Hatron P.Y., Michon-Pasturel U., Heblar M., Queyrel V., et al. Dépistage de l'hypertension artérielle pulmonaire au cours de la sclérodermie systémique: étude d'une cohorte de 67 patients. Rev Méd Interne. 22:2001;819-829
11. Mukerjee D., St George D., Coleiro B., Knight C., Denton C.P., Davar J., et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 62:2003;1088-1093
12. Sanchez O., Humbert M., Sitbon O., Nunès H., Garcia G., Simonneau G. Hypertension artérielle pulmonaire associée aux connectivites. Rev Méd Interne. 23:2002;41-54
13. Steen V., Medsger T.A. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum. 48:2003;516-522
14. Hoeper M.M. Pulmonary hypertension in collagen vascular disease. Eur Respir J. 19:2002;571-576
15. Humbert M., Sitbon O., Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;. sous presse
16. Badesch D.B., Tapson V.F., McGoon M.D., Brundage B.H., Rubin L.J., Wigley F.M., et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med. 132:2000;425-434
17. Denton C.P., Black C.M. for the 351 and BREATHE-1 Study Group. Bosentan for scleroderma associated pulmonary hypertension. A subgroup analysis of two controlled trials. Arthritis Rheum. 48:(Suppl):2003;S456
18. Kawut S.M., Taichman D.B., Archert-Chicko C.L., Palevsky H.I., Kimmel S.E. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest. 123:2003;344-350
19. Marie I., Levesque H., Hatron P.Y., Dominique S., Courtois H. Atteinte pulmonaire au cours de la sclérodermie systémique. Partie II. Hypertension artérielle pulmonaire isolée, cancer bronchopulmonaire, hémorragie alvéolaire. Rev Méd Interne. 20:1999;1017-1027
20. Denton C.P., Cailes J.B., Philips G.D., Wells A.U., Black C.M., Du Bois R.M. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol. 36:1997;239-243
21. Steen V., Medsger T.A. Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum. 48:2003;516-522
22. El Khattabi A., Tiev K.P., Ziani M., Barte M., Genereau T. Cabane et les membres du GFRS. Quelles sont les pratiques françaises pour le dépistage de l'hypertension artérielle pulmonaire associée à la sclérodermie systémique ? Enquête descriptive du Groupe Français de Recherche sur la Sclérodermie. Ann Méd Interne. 2004;. sous presse
23. Sitbon O., Humbert M., Ragot J.L., Taravella O., Fartoukh M., Parent F., et al. Inhaled nitric oxide as a screening agent for safety identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J. 12:1998;265-270